| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 270 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 1.008 | 732 | 782 | 753 | 1.032 | 738 | 963 | 972 | 578 | 415 |
| Gross Profit/Loss - EUR | -738 | -732 | -782 | -753 | -1.032 | -738 | -963 | -972 | -578 | -415 |
| Net Profit/Loss - EUR | -746 | -732 | -782 | -753 | -1.032 | -738 | -963 | -972 | -578 | -415 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmacosor S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.562 | 4.377 | 5.811 | 5.518 | 5.229 | 4.951 | 4.666 | 4.505 | 4.316 | 4.087 |
| Current Assets | 2.535 | 1.915 | 1.241 | 1.295 | 1.263 | 1.093 | 1.090 | 661 | 660 | 2.067 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 846 |
| Receivables | 985 | 1.054 | 1.102 | 1.082 | 1.061 | 1.040 | 1.017 | 624 | 622 | 196 |
| Cash | 1.550 | 861 | 139 | 214 | 203 | 53 | 72 | 37 | 38 | 1.025 |
| Shareholders Funds | -1.919 | -2.632 | -1.721 | -2.443 | -3.428 | -4.101 | -4.974 | -5.961 | -6.521 | -7.519 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.016 | 8.924 | 8.773 | 9.257 | 9.920 | 10.146 | 10.729 | 11.128 | 11.498 | 13.673 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Farmacosor S.r.l.